VOLTAREN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Voltaren, and what generic alternatives are available?

Voltaren is a drug marketed by Novartis and Haleon Us Holdings and is included in four NDAs.

The generic ingredient in VOLTAREN is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-five suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Voltaren

A generic version of VOLTAREN was approved as diclofenac sodium by ACTAVIS ELIZABETH on March 26^th, 1996.

Try a Trial

Summary for VOLTAREN

US Patents:	0
Applicants:	2
NDAs:	4
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	121
Clinical Trials:	54
Patent Applications:	3,851
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VOLTAREN
Drug Sales Revenues:	Drug sales revenues for VOLTAREN
What excipients (inactive ingredients) are in VOLTAREN?	VOLTAREN excipients list
DailyMed Link:	VOLTAREN at DailyMed

Drug patent expirations by year for VOLTAREN

Recent Clinical Trials for VOLTAREN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Rijeka	N/A
German University in Cairo	Phase 2
Cairo University	Phase 2

See all VOLTAREN clinical trials

Pharmacology for VOLTAREN

Drug Class	Anti-coagulant Calculi Dissolution Agent
Mechanism of Action	Acidifying Activity Calcium Chelating Activity
Physiological Effect	Decreased Coagulation Factor Activity

US Patents and Regulatory Information for VOLTAREN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-003	Jul 28, 1988		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-001	Jul 28, 1988		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VOLTAREN

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991	⤷ Try a Trial	⤷ Try a Trial
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-001	Jul 28, 1988	⤷ Try a Trial	⤷ Try a Trial
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-002	Jul 28, 1988	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VOLTAREN

See the table below for patents covering VOLTAREN around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0242328	PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION IN THE EYE	⤷ Try a Trial
Canada	1286225	MEDICAMENT POUR LE TRAITEMENT DES INFLAMMATIONS DE L'OEIL (MEDICAMENT FOR THE TREATMENT OF INFLAMMATIONS OF THE EYE)	⤷ Try a Trial
Portugal	84669	PROCESSO PARA A PREPARACAO DE UM MEDICAMENTO PARA O TRATAMENTO DE INFLAMACOES DOS OLHOS CONTENDO DICLOFENAC-SODIO	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration